TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas
Open Access
- 1 June 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 35 (6) , 1476-1484
- https://doi.org/10.1053/jhep.2002.33683
Abstract
We carried out molecular cytogenetic characterization of 11 cell lines derived from hepatocellular carcinomas (HCCs) and 51 primary HCCs. Comparative genomic hybridization (CGH) revealed frequent amplification at 13q34, where we had detected amplification in several other types of tumor, including esophageal squamous cell carcinomas (ESC). Previously, we suggested possible involvement of TFDP1, encoding a transcription factor DP-1, in the 13q34 amplification observed in a primary ESC. Therefore, we investigated amplifications and expression levels of 5 genes mapped on the amplified region, including TFDP1, for exploring amplification targets at 13q34 in HCCs. 3 of those genes, TFDP1, CUL4A (cullin 4A), and CDC16 (cell division cycle 16), showed distinct amplification and consequent over-expression in some cell lines. Moreover, each was amplified in 3 or 4 of the 51 primary HCCs, and all 3 were amplified in 2 tumors, in which their expression patterns correlated with amplification patterns. To elucidate the functional role of TFDP1 in HCC, we examined expression levels of genes downstream of TFDP1 with real-time quantitative polymerase chain reaction (PCR). Expression of cyclin E gene (CCNE1) correlated closely with that of TFDP1 in not only cell lines, but also primary tumors. Treatment of HCC cells with the antisense oligonucleotide targeting TFDP1 resulted in down-regulation of CCNE1, suggesting that TFDP1 overexpression led to up-regulation of CCNE1 that encoded a positive regulator for cell cycle G1/S transition. In conclusion, our findings suggest that TFDP1, CUL4A, and CDC16 are probable targets of an amplification mechanism and therefore may be involved, together or separately, in development and/or progression of some HCCs.Keywords
Funding Information
- Grants-in-Aid for Cancer Research from the Ministry of Education, Science, Sports and Culture, and the Ministry of Health and Welfare of Japan
This publication has 35 references indexed in Scilit:
- Nonrandom Chromosomal Imbalances in Esophageal Squamous Cell Carcinoma Cell Lines: Possible Involvement of the ATF3 and CENPF Genes in the 1q32 AmpliconJapanese Journal of Cancer Research, 2000
- CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell linesGenes, Chromosomes and Cancer, 2000
- Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell linesJournal of Human Genetics, 1999
- Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridizationBritish Journal of Cancer, 1999
- Genetic Aberrations Detected by Comparative Genomic Hybridization in Hepatocellular Carcinomas: Their Relationship to Clinicopathological FeaturesHepatology, 1999
- Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of theDP1 gene in the 13q34 ampliconGenes, Chromosomes and Cancer, 1999
- Novel Recurrent Genetic Imbalances in Human Hepatocellular Carcinoma Cell Lines Identified by Comparative Genomic HybridizationHepatology, 1999
- Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridizationGenes, Chromosomes and Cancer, 1999
- Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization AnalysisThe American Journal of Pathology, 1999
- Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridizationGenes, Chromosomes and Cancer, 1997